Category: Baxter InternationalSyndicate content

Medtech's $33m lobbying spend last year hits 16-year high

March 9, 2015 by Brad Perriello

The lobbying spend in Washington hit a 16-year high of nearly $33 million in 2014, as the industry continued its fight to repeal Obamacare's medical device tax.

Medtech's $33m lobbying spend is an all-time high

The medical device industry's lobbying spend hit its highest point since 1998 last year, nearing $33 million, as the industry stepped up its campaign to repeal the medical device tax enacted as part of Obamacare.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Baxter bests expectations with Q4 sales, earnings

February 3, 2015 by Brad Perriello

Baxter bests analysts' forecasts for its 4th-quarter results but issues a cautious outlook for the 1st quarter.

Baxter bests expectations with Q4 sales, earnings

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

China halts anti-dumping probe into EU, Japan dialysis kit makers

December 17, 2014 by MassDevice

China closes out an anti-dumoing probe into foreign dialysis kit makers including Fresenius, Nikkiso and Nipro.

China halts anti-dumping probe into EU, Japan dialysis kit makers

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Baxter IV container recall is Class I

November 21, 2014 by Mark Hollmer

The FDA slaps a Class I recall label on Baxter International's pullback of tainted containers used to prepare intravenous medicines.

Baxter IV container recall is Class I

Baxter's (NYSE:BAX) recall of tainted containers used to prepare intravenous medicines is drawing heightened FDA scrutiny. The regulatory agency slapped a Class I label on the effort, its most serious designation.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtech's betting on the GOP in midterm elections

October 24, 2014 by Brian Johnson

A look at the top 10 politicial action committee donations shows that medtech is betting heavily on a GOP win in the midterm elections.

Medtech's betting on the GOP in midterm elections

The medical device industry is betting on a Republican sweep of the U.S. Congress during the 2014 mid term elections, according to a MassDevice.com analysis of donations made by the industry's 10 largest political action committees.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medical products push Baxter profit above estimate

October 16, 2014 by MassDevice

Baxter's 3rd-quarter profits beat expectations, driven by its medical product business, but shares slide on a lowered earnings forecast.

Medical products push Baxter profit above estimate

(Reuters) - Medical device and drug maker Baxter (NYSE:BAX) reported a higher-than-expected quarterly profit, as sales in its medical products business continued to grow.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Baxter biopharm spinout Baxalta's R&D is Cambridge-bound

September 30, 2014 by Alex Soule

Baxter International confirmed Cambridge, Mass., as the new R&D hub for Baxalta, the planned spinout of its biopharmaceuticals business.

Baxter biopharm spinout Baxalta's R&D is Cambridge-bound